Narix Pharmaceuticals Private Limited

Neopride (Levosulpiride) Tablet Prokinetic + Anxiolytic for IBS, Gastroparesis & Anxiety Narix Pharmaceuticals Narix Pharmaceuticals manufactures Levosulpiride Tablets, the L-isomer of sulpiride with dual D2-blocking action in both GI tract (prokinetic) and CNS (anxiolytic) � uniquely treating digestive and psychiatric comorbidities simultaneously. Key Therapeutic Uses: � Irritable bowel syndrome (IBS) � prokinetic relief � Functional dyspepsia and gastroparesis � Anxiety and mild depression � Functional GI disorders with anxiety component Available Strengths: 25 mg 75 mg Product Highlights: � Dual GI + CNS action � unique positioning � Very high demand in India for functional GI disorders � WHO-GMP, DCGI approved � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #LevosulprideTablet #NeoprideGeneric #ProKineticTablet #IBSMedicine #FunctionalDyspepsia #GastroparesisMedicine #LevosulprideManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Xofluza (Baloxavir Marboxil) Tablet First-in-Class Cap-Dependent Endonuclease Inhibitor for Influenza Narix Pharmaceuticals Narix Pharmaceuticals manufactures Baloxavir Marboxil Tablets, the first-in-class cap-dependent endonuclease (CEN) inhibitor � a novel single-dose influenza treatment with a completely different mechanism from oseltamivir, effective even against oseltamivir-resistant strains. Key Therapeutic Uses: � Acute uncomplicated influenza A and B � single-dose treatment � Oseltamivir-resistant influenza strains � Influenza in high-risk patients � Post-exposure prophylaxis in household contacts Available Strengths: 20 mg 40 mg 80 mg Product Highlights: � Single-dose regimen � highest compliance � Novel CEN mechanism � no cross-resistance with oseltamivir � WHO-GMP, DCGI approved � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #BaloxavirTablet #XofluzaGeneric #CENInhibitor #SingleDoseFluTablet #InfluenzaMedicine #BaloxavirManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine #FirstInClassAntiviral

Lithobid (Lithium Carbonate) Tablet Gold Standard Mood Stabilizer for Bipolar Disorder Narix Pharmaceuticals Narix Pharmaceuticals manufactures Lithium Carbonate Tablets, the gold standard mood stabilizer for bipolar disorder with 70+ years of evidence � the only medication proven to reduce suicide risk in bipolar and depressed patients. Key Therapeutic Uses: � Bipolar disorder � acute mania and long-term prophylaxis � Suicide risk reduction in bipolar/depressed patients � Augmentation in treatment-resistant depression � Schizoaffective disorder � mood stabilization � Cluster headache prevention (off-label) Available Strengths: 150 mg 300 mg 400 mg 450 mg SR 600 mg Product Highlights: � Gold standard mood stabilizer � 70+ years evidence � Only drug proven to reduce suicide risk � WHO-GMP, DCGI approved � Serum level monitoring documentation provided � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #LithiumCarbonateTablet #LithobidGeneric #LicabGeneric #MoodStabilizer #BipolarMedicine #SuicidePrevention #LithiumManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine